Receptors, Interleukin-1 Type I
"Receptors, Interleukin-1 Type I" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An interleukin-1 receptor subtype that is involved in signaling cellular responses to INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The binding of this receptor to its ligand causes its favorable interaction with INTERLEUKIN-1 RECEPTOR ACCESSORY PROTEIN and the formation of an activated receptor complex.
Descriptor ID |
D053573
|
MeSH Number(s) |
D12.776.543.750.705.852.420.300.500
|
Concept/Terms |
Receptors, Interleukin-1 Type I- Receptors, Interleukin-1 Type I
- Receptors, Interleukin 1 Type I
- CD121a Antigens
- Receptor Type I, Interleukin-1
- Receptor Type I, Interleukin 1
- Interleukin-1 Receptor Type I
- Interleukin 1 Receptor Type I
- Antigens, CDw121a
- CDw121a Antigens
- Interleukin-1 Receptors Type I
- Interleukin 1 Receptors Type I
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Interleukin-1 Type I".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Interleukin-1 Type I".
This graph shows the total number of publications written about "Receptors, Interleukin-1 Type I" by people in this website by year, and whether "Receptors, Interleukin-1 Type I" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 0 | 1 | 1 | 1999 | 0 | 1 | 1 | 2001 | 0 | 1 | 1 | 2004 | 0 | 1 | 1 | 2005 | 0 | 1 | 1 | 2007 | 1 | 0 | 1 | 2008 | 2 | 0 | 2 | 2009 | 0 | 1 | 1 | 2011 | 0 | 2 | 2 | 2015 | 0 | 2 | 2 | 2016 | 1 | 0 | 1 | 2018 | 1 | 1 | 2 | 2020 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Receptors, Interleukin-1 Type I" by people in Profiles.
-
Wang Q, Notay K, Downey GP, McCulloch CA. The Leucine-Rich Repeat Region of CARMIL1 Regulates IL-1-Mediated ERK Activation, MMP Expression, and Collagen Degradation. Cell Rep. 2020 06 30; 31(13):107781.
-
Abbate A, Toldo S, Marchetti C, Kron J, Van Tassell BW, Dinarello CA. Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease. Circ Res. 2020 04 24; 126(9):1260-1280.
-
Wade MF, Collins MK, Richards D, Mack DG, Martin AK, Dinarello CA, Fontenot AP, McKee AS. TLR9 and IL-1R1 Promote Mobilization of Pulmonary Dendritic Cells during Beryllium Sensitization. J Immunol. 2018 10 15; 201(8):2232-2243.
-
Ballak DB, Li S, Cavalli G, Stahl JL, Tengesdal IW, van Diepen JA, Kl?ck V, Swartzwelter B, Azam T, Tack CJ, Stienstra R, Mandrup-Poulsen T, Seals DR, Dinarello CA. Interleukin-37 treatment of mice with metabolic syndrome improves insulin sensitivity and reduces pro-inflammatory cytokine production in adipose tissue. J Biol Chem. 2018 09 14; 293(37):14224-14236.
-
Ingiosi AM, Opp MR. Sleep and immunomodulatory responses to systemic lipopolysaccharide in mice selectively expressing interleukin-1 receptor 1 on neurons or astrocytes. Glia. 2016 May; 64(5):780-91.
-
Gill RG, Pagni PP, Kupfer T, Wasserfall CH, Deng S, Posgai A, Manenkova Y, Bel Hani A, Straub L, Bernstein P, Atkinson MA, Herold KC, von Herrath M, Staeva T, Ehlers MR, Nepom GT. A Preclinical Consortium Approach for Assessing the Efficacy of Combined Anti-CD3 Plus IL-1 Blockade in Reversing New-Onset Autoimmune Diabetes in NOD Mice. Diabetes. 2016 05; 65(5):1310-6.
-
Mezzaroma E, Mikkelsen RB, Toldo S, Mauro AG, Sharma K, Marchetti C, Alam A, Van Tassell BW, Gewirtz DA, Abbate A. Role of Interleukin-1 in Radiation-Induced Cardiomyopathy. Mol Med. 2015 Mar 26; 21:210-8.
-
Lingappa JR, Dumitrescu L, Zimmer SM, Lynfield R, McNicholl JM, Messonnier NE, Whitney CG, Crawford DC. Identifying host genetic risk factors in the context of public health surveillance for invasive pneumococcal disease. PLoS One. 2011; 6(8):e23413.
-
Wu Y, Lousberg EL, Moldenhauer LM, Hayball JD, Robertson SA, Coller JK, Watkins LR, Somogyi AA, Hutchinson MR. Attenuation of microglial and IL-1 signaling protects mice from acute alcohol-induced sedation and/or motor impairment. Brain Behav Immun. 2011 Jun; 25 Suppl 1:S155-64.
-
Ben-Sasson SZ, Hu-Li J, Quiel J, Cauchetaux S, Ratner M, Shapira I, Dinarello CA, Paul WE. IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation. Proc Natl Acad Sci U S A. 2009 Apr 28; 106(17):7119-24.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|